letter
editor
palivizumab
use
respiratori
syncyti
viru
outbreak
neonat
intens
care
unit
read
great
interest
paper
dizdar
et
al
oconnel
et
al
use
palivizumab
respiratori
syncyti
viru
rsv
outbreak
neonat
intens
care
unit
nicu
suggest
palivizumab
administr
might
role
control
rsv
outbreak
recommend
earli
administr
palivizumab
termin
transmiss
quickli
possibl
recent
experienc
similar
outbreak
nicu
control
accord
suggest
made
paper
ten
preterm
median
gestat
age
week
rang
week
birth
weight
g
two
late
preterm
week
gestat
age
four
term
infant
nicu
two
term
newborn
bronchopneumonia
respiratori
insuffici
admit
nicu
isol
unit
februari
march
polymeras
chain
reaction
pcr
screen
includ
rsv
b
coronaviru
b
c
e
parainfluenza
rhinoviru
b
c
influenza
b
bocaviru
metapneumoviru
enteroviru
reveal
rsv
type
b
infect
two
patient
although
patient
rsv
care
separ
isol
room
anoth
preterm
infant
recov
respiratori
distress
syndrom
develop
respiratori
distress
week
nasopharyng
secret
obtain
infant
also
reveal
rsv
type
b
infect
decid
screen
remain
infant
rsv
none
asymptomat
patient
rsv
pcr
posit
order
prevent
escal
nicu
outbreak
palivizumab
prophylaxi
administ
nine
preterm
infant
week
gestat
age
birth
one
patient
congenit
heart
diseas
dosag
mgkg
addit
strict
contact
precaut
patient
rsv
bronchiol
recov
day
observ
addit
case
rsv
rsv
infect
brought
nicu
two
patient
rsv
bronchiol
follow
one
preterm
patient
recov
respiratori
distress
develop
rsv
bronchiol
nicu
like
embrac
familycentr
model
patient
care
greater
difficulti
compli
effect
infect
control
measur
may
emerg
agre
dizdar
et
al
oconnel
et
al
palivizumab
prophylaxi
may
role
control
rsv
epidem
nicu
given
palivizumab
prophylaxi
detect
index
case
larger
rsv
outbreak
might
occur
nicu
small
rsv
nicu
outbreak
turkey
turkish
neonat
societi
recommend
rsv
prophylaxi
prematur
infant
nicu
alreadi
candid
prophylaxi
programm
outpati
least
three
rsvposit
patient
present
nicu
recommend
similar
one
report
spanish
neonat
societi
suggest
palivizumab
prophylaxi
preterm
infant
newborn
haemodynam
signific
congenit
heart
diseas
outbreak
occur
conflict
interest
statement
none
declar
none
would
like
highlight
import
princip
find
vickeri
et
al
multidrugresist
organ
found
biofilm
form
dri
hospit
surfac
despit
clean
disinfect
biofilm
problemat
healthcar
set
thought
respons
nosocomi
infect
usual
report
relat
variou
indwel
medic
devic
prosthes
water
line
tube
endoscop
wound
set
biofilm
persist
prolong
period
slough
releas
plankton
bacteria
may
act
infect
sourc
howev
knowledg
vickeri
et
al
provid
first
report
biofilm
hard
dri
hospit
surfac
import
implic
organ
biofilm
exhibit
alter
phenotyp
compar
correspond
plankton
cell
especi
regard
growth
gene
transcript
protein
product
intercellular
interact
biofilm
form
almost
biolog
inanim
surfac
identifi
variou
industri
medic
set
constitut
protect
mode
growth
allow
bacteria
surviv
hostil
environ
confer
reduc
suscept
dehydr
phagocytosi
ultraviolet
light
metal
toxic
acid
exposur
antimicrobi
agent
includ
antibiot
disinfect
germicid
find
biofilm
dri
hospit
surfac
strengthen
import
sever
recent
studi
exampl
epist
et
al
found
biofilmform
strain
acinetobact
baumannii
surviv
longer
dri
surfac
nonbiofilmform
strain
vs
day
p
conclud
abil
form
biofilm
may
contribut
persist
hospit
environ
increas
probabl
caus
nosocomi
infect
outbreak
also
recent
data
indic
bacteria
live
biofilm
time
less
suscept
antibacteri
compound
correspond
plankton
bacteria
exampl
smith
et
al
grew
biofilm
clinic
isol
meticillinresist
staphylococcu
aureu
mrsa
pseudomona
aeruginosa
disc
materi
found
hospit
environ
treat
three
commonli
use
hospit
biocid
biocid
ineffect
kill
bacteria
concentr
recommend
use
consider
higher
minimum
bactericid
concentr
mbc
plankton
popul
organ
mbc
three
biocid
found
higher
biofilm
concentr
recommend
use
follow
biocid
treatment
cell
mrsa
biofilm
cell
p
aeruginosa
biofilm
surviv
studi
suggest
although
biocid
may
effect
plankton
popul
bacteria
biocid
current
use
hospit
ineffect
nosocomi
pathogen
grow
biofilm
attach
surfac
could
miss
underestim
import
biofilm
dri
hospit
surfac
could
mechan
reservoir
veget
bacteri
pathogen
persist
within
hospit
environ
extend
period
could
also
part
reason
disinfect
effect
inactiv
plankton
bacteria
laboratori
test
effect
erad
consider
lower
load
bacteri
speci
hospit
surfac
support
note
biofilm
identifi
vickeri
et
al
surfac
clean
use
deterg
disinfect
use
ppm
chlorin
presenc
biofilm
dri
hospit
surfac
could
also
interfer
attempt
recov
microb
environment
sampl
could
mean
environment
reservoir
pathogen
remain
undetect
concentr
contamin
degre
associ
risk
underestim
biofilm
clearli
reason
failur
hospit
disinfect
given
difficulti
achiev
adequ
distribut
contact
time
use
manual
method
find
may
implic
infect
control
practic
within
hospit
choic
appropri
disinfect
hospit
surfac
particularli
relev
bacteri
cell
aqueou
plankton
phase
remain
common
model
mani
microbiolog
studi
includ
disinfect
test
futur
test
consid
inclus
biofilm
model
ensur
disinfect
test
effect
real
world
laboratori
test
